IDXX Stock: Price, Earnings History and SEC Filings
IDEXX Laboratories, Inc. (IDXX) last traded at $551.21, down 4.30% on the latest session and up 5.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $4.27 against an analyst estimate of $3.95, a beat of 8.1%.
$551.21 -4.30%
1 month+5.56%
52-week high$769.98
52-week low$500.61
Volume1.17M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
IDXX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $4.27 | $3.95 | +8.10% |
| Mar 2026 | May 5, 2026 | $3.47 | $3.42 | +1.46% |
| Dec 2025 | Feb 2, 2026 | $3.08 | $2.93 | +5.12% |
| Sep 2025 | Nov 3, 2025 | $3.40 | $3.14 | +8.28% |
IDXX beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for IDXX
SEC filing data is not available right now. You can search for IDXX on SEC EDGAR.
IDXX news
- IDEXX Laboratories (IDXX) Stock Looks Fairly Valued Despite Its 28% RunOct 31, 2026 · finance.yahoo.com
- Cencora Gears Up to Report Q4 Results: How to Play the Stock?Oct 30, 2026 · finance.yahoo.com
- Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?Oct 30, 2026 · finance.yahoo.com
- STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock?Oct 30, 2026 · finance.yahoo.com
- IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?Oct 30, 2026 · trefis.com
- Zoetis (ZTS) vs. IDXX and ELAN: Is Valuation Compression Creating a Rare Opportunity in Animal Health?Oct 29, 2026 · finance.yahoo.com
- IDXX - IDEXX Laboratories, Inc.Oct 29, 2026 · seekingalpha.com
- BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?Oct 29, 2026 · finance.yahoo.com
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) is a US-listed public company on Nasdaq.